SS Innovations (Nasdaq: SSII) has successfully completed the world’s longest-distance robotic telesurgery, the company announced today.
On May 26, SS Innovations CEO Dr. Sudhir Srivastava remotely performed a cardiac procedure on a patient located 12,500 miles away (via fiber network) in Indore, India, using the company’s SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console in Georgetown, Guyana.
“The successful completion of this intercontinental cardiac telesurgery between Guyana and India, at a world-record distance of 12,500 miles, marks a historic milestone for SS Innovations and our SSi Mantra surgical robotic system,” said Srivastava in a news release. “With each new remote procedure, we continue to push the boundaries of telesurgery and move closer to democratizing access to world-class surgical expertise globally.”
Related: Can surgical robots fly? SSi’s CEO discusses the challenges and solutions
Srivastava performed a left internal mammary artery takedown at Georgetown Public Hospital Corporation ulitizing SSi’s MantrAsana tele-surgeon console while several surgeons served as the bedside support surgeons at the hospital in India with the patient.
The system functioned with a network latency of 290-300 milliseconds, allowing communication between both locations during the surgery, SS Innovations said.
SSi’s MantrAsana tele-surgeon console is a compact version of the company’s SSi Mantra surgeon command center, requiring less space, which enables telesurgies to be performed from a range of locations, including physician offices, the company said.
The MantrAsana was engineered for real-time remote procedures through ultra-low latency connectivity, high-definition 3D visualization and precise remote control of robotic arms and instruments, SS Innovation said.
SS Innovation’s Mantra robotic system features three to five modular robotic arms with procedure-specific use and tools, and includes a vision cart for operating room staff to visualize what the remote surgeon sees.
The intercontinental surgery comes less than one month after SS Innovations completed a 4,500-mile cross-border robotic telesurgery on a patient in India performed by a surgeon in Perth, Australia.
As of publication, 173 telesurgeries have been performed with SSi’s Mantra system, which has regulatory approval in twelve countries, the company said.
SS Innovations submitted a 510(k) premarket notification to the FDA for its Mantra 3 robotic surgery system in December 2025, seeking indications in general, urological, colorectal, gynecological and cardiac surgery.
